Search research articles
Contact Us
Filters
Showing results (1-10 of 21) with videos related to
Page
of 3
Sort By:
Mutation Research. Genetic Toxicology and Environmental Mutagenesis
|
September 15, 2020
Assessment of the miniaturized liquid Ames microplate format (MPF™) for a selection of the test items from the recommended list of genotoxic and non-genotoxic chemicals
Dimitrios Spiliotopoulos, Cécile Koelbert
Drug Discovery Today. Technologies
|
October 23, 2016
Fragment-based in silico screening of bromodomain ligands
Dimitrios Spiliotopoulos, Amedeo Caflisch
Plos One
|
October 19, 2012
Exploring PHD fingers and H3K4me0 interactions with molecular dynamics simulations and binding free energy calculations: AIRE-PHD1, a comparative study
Dimitrios Spiliotopoulos, Andrea Spitaleri, Giovanna Musco
Bioorganic & Medicinal Chemistry Letters
|
April 29, 2014
Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking
Hongtao Zhao, Lisa Gartenmann, Jing Dong, et al.
European Journal of Medicinal Chemistry
|
August 25, 2017
Discovery of BAZ2A bromodomain ligands
Dimitrios Spiliotopoulos, Eike-Christian Wamhoff, Graziano Lolli, et al.
European Journal of Medicinal Chemistry
|
May 12, 2019
Ligand retargeting by binding site analogy
Lars Wiedmer, Claude Schärer, Dimitrios Spiliotopoulos, et al.
Journal of Medicinal Chemistry
|
July 1, 2015
Discovery of CREBBP Bromodomain Inhibitors by High-Throughput Docking and Hit Optimization Guided by Molecular Dynamics
Min Xu, Andrea Unzue, Jing Dong, et al.
Journal of Medicinal Chemistry
|
June 5, 2015
Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain
Andrea Unzue, Min Xu, Jing Dong, et al.
American Journal of Medical Genetics. Part A
|
May 1, 2014
Identification of a novel de novo deletion in RAF1 associated with biventricular hypertrophy in Noonan syndrome
Maria Elena Sana, Andrea Spitaleri, Dimitrios Spiliotopoulos, et al.
ACS Medicinal Chemistry Letters
|
January 16, 2015
Structural Analysis of the Binding of Type I, I1/2, and II Inhibitors to Eph Tyrosine Kinases
Jing Dong, Hongtao Zhao, Ting Zhou, et al.
Page
of 3
Search research articles
Search
Showing results (1-10 of 21) with videos related to
Sort By:
Page
of 3
Mutation Research. Genetic Toxicology and Environmental Mutagenesis
|
September 15, 2020
Assessment of the miniaturized liquid Ames microplate format (MPF™) for a selection of the test items from the recommended list of genotoxic and non-genotoxic chemicals
Dimitrios Spiliotopoulos, Cécile Koelbert
Drug Discovery Today. Technologies
|
October 23, 2016
Fragment-based in silico screening of bromodomain ligands
Dimitrios Spiliotopoulos, Amedeo Caflisch
Plos One
|
October 19, 2012
Exploring PHD fingers and H3K4me0 interactions with molecular dynamics simulations and binding free energy calculations: AIRE-PHD1, a comparative study
Dimitrios Spiliotopoulos, Andrea Spitaleri, Giovanna Musco
Bioorganic & Medicinal Chemistry Letters
|
April 29, 2014
Discovery of BRD4 bromodomain inhibitors by fragment-based high-throughput docking
Hongtao Zhao, Lisa Gartenmann, Jing Dong, et al.
European Journal of Medicinal Chemistry
|
August 25, 2017
Discovery of BAZ2A bromodomain ligands
Dimitrios Spiliotopoulos, Eike-Christian Wamhoff, Graziano Lolli, et al.
European Journal of Medicinal Chemistry
|
May 12, 2019
Ligand retargeting by binding site analogy
Lars Wiedmer, Claude Schärer, Dimitrios Spiliotopoulos, et al.
Journal of Medicinal Chemistry
|
July 1, 2015
Discovery of CREBBP Bromodomain Inhibitors by High-Throughput Docking and Hit Optimization Guided by Molecular Dynamics
Min Xu, Andrea Unzue, Jing Dong, et al.
Journal of Medicinal Chemistry
|
June 5, 2015
Fragment-Based Design of Selective Nanomolar Ligands of the CREBBP Bromodomain
Andrea Unzue, Min Xu, Jing Dong, et al.
American Journal of Medical Genetics. Part A
|
May 1, 2014
Identification of a novel de novo deletion in RAF1 associated with biventricular hypertrophy in Noonan syndrome
Maria Elena Sana, Andrea Spitaleri, Dimitrios Spiliotopoulos, et al.
ACS Medicinal Chemistry Letters
|
January 16, 2015
Structural Analysis of the Binding of Type I, I1/2, and II Inhibitors to Eph Tyrosine Kinases
Jing Dong, Hongtao Zhao, Ting Zhou, et al.
Page
of 3